Loading company details...
Beta
Latest Form 4 (Aug 12, 2026): Charles S. Fuchs (President, R&D): Grant/Award of 1,300,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 12, 2026 | Charles S. Fuchs, President, R&D | Grant/Award | 1,300,000 | n/a |
| Jun 29, 2026 | Valerie Denise Harding Start | Grant/Award | 29,888 | n/a |
| Jun 29, 2026 | Jean I. Liu | Grant/Award | 29,888 | n/a |
| Jun 29, 2026 | Pratik S. Multani | Grant/Award | 29,888 | n/a |
| Jun 29, 2026 | Alexander W. Casdin | Grant/Award | 29,888 | n/a |
| Jun 29, 2026 | Julie Hambleton | Grant/Award | 29,888 | n/a |
| Jun 29, 2026 | James Arthur Bristol | Grant/Award | 29,888 | n/a |
| Apr 3, 2026 | Ebun Garner, Chief Legal Officer | Exercise/Conversion | 80,000 | $136.0K |
| Mar 6, 2026 | Shannon Morris, Chief Medical Officer | Exercise/Conversion | 20,000 | $34.0K |
| Jan 30, 2026 | Jonathan E. Lim, Chairman & CEO | Grant/Award | 2,000,000 | n/a |